|
|
|
|
|
by xr4ti
3094 days ago
|
|
The FDA specifically (and famously) does not regulate the practice of medicine. They regulate the marketing of drugs and medical devices - mainly that you cannot market something as an safe and effective treatment for a disease/condition without proof of (a) safety and (b) efficacy (or effectiveness), which is obtained through clinical trials. Adherence to "evidence based" therapy guidelines is typically enforced via malpractice claims. Obamacare tried to introduce incentives for outcome measurement/tracking and evidence based care by either cutting or supplementing medicare reimbursements, but even that has been difficult to implement nationally across the 5-7 most frequent and costly conditions and procedures (e.g. acute myocardial infarction, COPD, knee replacement, etc). While the FDA's regulatory approach does slow the pace of innovation, they exist for a reason -- I acknowledge that GP is not calling for any policy change. Snake oil salesmen were a real thing, and still abound in the valley albeit in different form. |
|
So to say that the issue is funding for FDA approval is probably an oversimplification- equally powerful studies without FDA involvement may or may not suffice, that's a question having to do with law and other non-science factors. But the FDA has established what is the broadly recognized "gold standard" of establishing the medical effectiveness of an intervention.